Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Zivo Bioscience Inc. currently manages 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. This workload is distributed across 3 distinct examiners and 3 distinct art units, indicating a broad spread of examination oversight for the portfolio. The alignment of these matters suggests that each case is receiving individual attention from a different official rather than being grouped under a single reviewer.
The busiest examiner for this company is BOECKELMAN, JACOB A, who is responsible for 1 pending office action. Because the total volume is split equally among the 3 distinct examiners, no single official holds a majority of the current prosecution load. This lack of concentration across the 3 distinct art units may require diverse strategies for responding to the USPTO. Practitioners should note that the assigned examiners may have varying procedural preferences despite working within the same technology area.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BOECKELMAN, JACOB A | 1 | 35.2% | +45.6% |
| DURYEE, ALEXANDER MARSH | 1 | 33.3% | +41.6% |
| XU, QING | 1 | 50.9% | +55.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17410016 | NATURAL FEED COMPOSITION DERIVED FROM FRESH WATER ALGAL CULTURES FOR THE PROMOTION OF ANIMAL GROWTH | XU, QING | 58d overdue |
| 17587582 | MATURATION OF IMMUNE AND METABOLIC PROCESSES VIA ALGAL BIOMASS AND/OR RELATED MATERIAL ADMINISTERED TO ANIMALS | DURYEE, ALEXANDER MARSH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17410016 | NATURAL FEED COMPOSITION DERIVED FROM FRESH WATER ALGAL CULTURES FOR THE PROMOTION OF ANIMAL GROWTH | XU, QING | 58d overdue |
| 18077132 | BREVUNDIMONAS SP FOR USE IN DISEASE PREVENTION AND TREATMENT | BOECKELMAN, JACOB A | — |
| 17587582 | MATURATION OF IMMUNE AND METABOLIC PROCESSES VIA ALGAL BIOMASS AND/OR RELATED MATERIAL ADMINISTERED TO ANIMALS | DURYEE, ALEXANDER MARSH | — |
| Art Unit | Apps |
|---|---|
| 1655 | 1 |
| 1657 | 1 |
| 1656 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18077132 | BREVUNDIMONAS SP FOR USE IN DISEASE PREVENTION AND TREATMENT | BOECKELMAN, JACOB A | 1655 | §112Other | Final Rejection | — | Pending | Dec 07, 2022 |
| 17587582 | MATURATION OF IMMUNE AND METABOLIC PROCESSES VIA ALGAL BIOMASS AND/OR RELATED MATERIAL ADMINISTERED TO ANIMALS | DURYEE, ALEXANDER MARSH | 1657 | §103§112 | Final Rejection | — | Pending | Jan 28, 2022 |
| 17410016 | NATURAL FEED COMPOSITION DERIVED FROM FRESH WATER ALGAL CULTURES FOR THE PROMOTION OF ANIMAL GROWTH | XU, QING | 1656 | §103§112 | Final Rejection | 58d overdue | Pending | Aug 24, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial